July 20, 2016
CTI Clinical Trial & Consulting Services Health Economics and Outcomes Research Experts Win John M. Eisenberg Article-of-the Year Award
FOR IMMEDIATE RELEASE [Cincinnati, OH ~ July 20, 2016]
CTI Clinical Trial and Consulting Services (CTI) announces that Guy David, PhD and Candace Gunnarsson, EdD won the John M. Eisenberg Article-of-the-Year Award for their work in Health Services Research. The award, which recognizes “excellence and original research” was announced earlier this month at the annual HSR Editorial Board meeting. The award winning article, entitled “Do Patient-Centered Medical Homes Reduce Emergency Department Visits?”, examines Independent Blue Cross of Pennsylvania data from 460,000 patients treated in patient-centered medical homes throughout Philadelphia and surrounding counties from 2008 to 2011.
“We’re incredibly proud of both Guy and Candace for their efforts on this article, and are fortunate to have such extraordinary Health Economics and Outcomes expertise at CTI,” according to Lynn Fallon, President.
Dr. Candace Gunnarsson is Vice President, Health Economics and Outcomes Research at CTI, with over 25 years of statistical and health economics experience. She works on a multitude of projects in Health Outcomes and Economics and has numerous publications in peer review clinical and health service journals. Prior to joining CTI, Candace was Founder and President of S2 Statistical Solutions, Inc., which was acquired by CTI in 2013. She has been a professor and guest lecturer with ten years of experience teaching undergraduate and graduate statistics courses. Currently she provides curriculum oversight and teaches at Xavier University as a part of their new HECOR Master Degree program.
Dr. David is an Academic Affiliate at CTI and an Associate Professor of both Health Care Management at the Wharton School and Health Policy and Medical Ethics at the Perelman School of Medicine. He is also the Director of Education at the Leonard Davis Institute of Health Economics (LDI) and Director of the Doctoral Program in Health Care Management and Economics at Wharton.
Additional co-authors of the award winning piece include Philip Saynisch, a Harvard Health Policy Management PhD student and Ravi Chawla and Somesh Nigam of the Independence Blue Cross Department of Informatics.
About CTI Clinical Trial and Consulting Services
CTI Clinical Trial and Consulting Services is a global, privately held, full-service contract research organization (CRO), delivering a complete spectrum of clinical trial and consulting services throughout the lifecycle of development, from concept to commercialization. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology, and medical device firms with clinical and disease area expertise in rare diseases, regenerative medicine/gene therapy, immunology, transplantation, nephrology, hematology/oncology, neurology, infectious diseases, hepatology, cardiopulmonary, and pediatric populations. CTI also offers a fully integrated multi-specialty clinical research site that conducts phase I-IV trials. CTI has a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. With clinical trial experience across 6 continents, CTI partners with research sites, patients, and sponsors to fulfill unmet medical needs. CTI is headquartered in Cincinnati, OH, with operations across North America, Europe, Latin America, and Asia-Pacific. For more information visit www.ctifacts.com